Targeting Pol I to Selectively Activate p53 and Kill
Cancer Cells
|
|||
Cancer is a disease of dysregulated cellular growth and
signaling characterized by the loss or gain of function-through mutation or
epigenetic change-of important regulatory proteins and cellular processes.
Foremost among these is the tumor suppressor protein known as p53.
|
Tracks information on drugs on worldwide basis by Dr Anthony Melvin Crasto, helping millions with websites, 9 million hits on google, 2.5 lakh connections worldwide, P.S. : The views expressed are my personal and in no-way suggest the views of the professional body or the company that I represent.
Tuesday, 11 June 2013
Targeting Pol I to Selectively Activate p53 and Kill Cancer Cells
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment